Mirum Pharmaceuticals Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Scroll to see more
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Valuation Ratios
P/S Ratio5.897.389.3225.41
P/B Ratio8.805.535.064.042.97
Price/Tangible Book8.654.792.97
Price/FCF212.71
Price/OCF192.25
Enterprise Value Ratios
EV/Revenue5.997.396.9515.62
EV/FCF216.27
Profitability & Returns
Return on Equity (ROE)-0.37%-0.84%-1.03%-0.57%-0.68%
Return on Assets (ROA)-0.08%-0.14%-0.25%-0.40%-0.34%
Return on Capital Employed (ROCE)-0.16%-0.20%-0.46%-0.69%-0.47%
Leverage & Solvency Ratios
Debt/Equity1.411.240.010.020.02
Debt/FCF34.05
Liquidity Ratios
Current Ratio3.104.452.943.9112.80
Quick Ratio2.834.072.713.7612.56
Efficiency Ratios
Asset Turnover0.510.370.240.07
Inventory Turnover3.653.383.50
Yield & Distribution Ratios
Earnings Yield-0.04%-0.12%-0.19%-0.17%-0.20%
FCF Yield0.00%-0.05%-0.17%-0.27%-0.17%
Buyback Yield-0.16%-0.20%-0.12%-0.20%-1.20%